Compounded Semaglutide and Tirzepatide in Connecticut

Quick answer: Connecticut residents can access compounded semaglutide and compounded tirzepatide through telehealth, with no in-person visit required. Fig serves all 50 states, including Connecticut. You complete a free online health assessment, a U.S.-licensed provider reviews your medical history, and medication is prescribed only if it is clinically appropriate for you. Fig's plans start at $145/month* for compounded semaglutide and $258/month* for compounded tirzepatide, with no membership fee and free shipping. Compounded medications are not FDA-approved.

For residents of Connecticut looking for medically supervised weight management, Fig provides an affordable, fully online telehealth option. Eligible patients can access compounded semaglutide or compounded tirzepatide starting at $145/month, with no membership fees and no insurance required.

How Fig Works in Connecticut

Getting started with Fig in Connecticut is designed to be simple and discreet:

1. Online Assessment: Complete a brief health questionnaire from the comfort of your home.

2. Provider Review: A U.S.-licensed medical provider will review your health profile to determine if a GLP-1 medication is clinically appropriate.

3. Delivery: If prescribed, your medication is prepared by a licensed compounding pharmacy and shipped directly to your door in Connecticut.

Transparent Pricing

Fig believes in straightforward pricing with no hidden fees or required memberships.

• Compounded Semaglutide: Plans start at $145/month.

• Compounded Tirzepatide: Plans start at $258/month.

The price includes your medical consultation, ongoing provider support, and free shipping to Connecticut.

Is Compounded Medication Safe?

Compounded medications prescribed through Fig are prepared by licensed, FDA-registered 503A compounding pharmacies that adhere to strict quality standards. While compounded medications are not FDA-approved, they are a legal and widely used option when commercially available alternatives are inaccessible or cost-prohibitive.

Start Your Journey Today

Residents of Connecticut can begin their evaluation immediately. There is no charge for the initial consultation, and you only pay if you are approved for treatment.

Check My Eligibility

Keep reading

Comparing providers? Browse the full GLP-1 provider comparison library, or see all guides in the Fig Journal.

Related: What Are GLP-1s? The Science Behind Modern Weight Management

Also helpful: How Much Does Semaglutide Cost Without Insurance in 2026?

Important Safety Information: Common side effects of compounded semaglutide and compounded tirzepatide may include nausea, vomiting, diarrhea, stomach pain, and constipation. Serious side effects may include inflammation of the pancreas (pancreatitis), gallbladder problems, increased risk of low blood sugar (hypoglycemia), kidney problems, and serious allergic reactions. These medications should not be used if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Telehealth Disclosure: Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. A prescription is not guaranteed. Rx required. Not available in all states. The information provided on this website is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Compounding Disclosure: Compounded products are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded semaglutide and compounded tirzepatide are not the same as, nor substitutes for, FDA-approved semaglutide products (Wegovy®, Ozempic®) or tirzepatide products (Mounjaro®, Zepbound®). Compounded medications are not generic drugs. Fig is partnered with state-licensed, FDA-registered 503A compounding pharmacies that prepare all medications.